REGENERON PHARMACEUTICALS, INC. Quarterly Debt-to-equity in % from Q1 2011 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Regeneron Pharmaceuticals, Inc. quarterly Debt-to-equity history and growth rate from Q1 2011 to Q3 2024.
  • Regeneron Pharmaceuticals, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 27.6 %, a 2.89% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 27.6 -0.82 -2.89% Sep 30, 2024
Q2 2024 27.9 -0.44 -1.55% Jun 30, 2024
Q1 2024 27.9 -1.45 -4.95% Mar 31, 2024
Q4 2023 28 -2.37 -7.8% Dec 31, 2023
Q3 2023 28.4 -3.59 -11.2% Sep 30, 2023
Q2 2023 28.4 -5.6 -16.5% Jun 30, 2023
Q1 2023 29.3 -7.1 -19.5% Mar 31, 2023
Q4 2022 30.4 -9.58 -24% Dec 31, 2022
Q3 2022 32 -12.6 -28.3% Sep 30, 2022
Q2 2022 34 -16.3 -32.4% Jun 30, 2022
Q1 2022 36.4 -18.7 -34% Mar 31, 2022
Q4 2021 40 -9.85 -19.8% Dec 31, 2021
Q3 2021 44.6 +0.58 +1.32% Sep 30, 2021
Q2 2021 50.3 +12.5 +33.2% Jun 30, 2021
Q1 2021 55.1 +22.5 +69% Mar 31, 2021
Q4 2020 49.8 +15.6 +45.4% Dec 31, 2020
Q3 2020 44 +9.6 +27.9% Sep 30, 2020
Q2 2020 37.7 +2.17 +6.1% Jun 30, 2020
Q1 2020 32.6 -3.71 -10.2% Mar 31, 2020
Q4 2019 34.3 -3.54 -9.36% Dec 31, 2019
Q3 2019 34.4 -5.65 -14.1% Sep 30, 2019
Q2 2019 35.6 -6.21 -14.9% Jun 30, 2019
Q1 2019 36.4 -7.55 -17.2% Mar 31, 2019
Q4 2018 37.8 -10.1 -21% Dec 31, 2018
Q3 2018 40.1 -11.2 -21.8% Sep 30, 2018
Q2 2018 41.8 -12 -22.3% Jun 30, 2018
Q1 2018 43.9 -11.7 -21% Mar 31, 2018
Q4 2017 47.9 -6.54 -12% Dec 31, 2017
Q3 2017 51.3 -2.26 -4.22% Sep 30, 2017
Q2 2017 53.8 -1.01 -1.84% Jun 30, 2017
Q1 2017 55.6 +4.59 +9% Mar 31, 2017
Q4 2016 54.4 +7.22 +15.3% Dec 31, 2016
Q3 2016 53.5 +7.56 +16.4% Sep 30, 2016
Q2 2016 54.8 +12 +27.9% Jun 30, 2016
Q1 2016 51 +5.13 +11.2% Mar 31, 2016
Q4 2015 47.2 -0.45 -0.95% Dec 31, 2015
Q3 2015 46 -1.55 -3.26% Sep 30, 2015
Q2 2015 42.9 -6.76 -13.6% Jun 30, 2015
Q1 2015 45.9 -6.9 -13.1% Mar 31, 2015
Q4 2014 47.6 -8.88 -15.7% Dec 31, 2014
Q3 2014 47.5 -13 -21.5% Sep 30, 2014
Q2 2014 49.6 -19.8 -28.5% Jun 30, 2014
Q1 2014 52.8 -31.5 -37.3% Mar 31, 2014
Q4 2013 56.5 -72.9 -56.3% Dec 31, 2013
Q3 2013 60.6 -123 -67% Sep 30, 2013
Q2 2013 69.4 -140 -66.9% Jun 30, 2013
Q1 2013 84.2 -122 -59.2% Mar 31, 2013
Q4 2012 129 -2.41 -1.83% Dec 31, 2012
Q3 2012 183 +68.5 +59.7% Sep 30, 2012
Q2 2012 210 +88 +72.2% Jun 30, 2012
Q1 2012 206 +85.5 +70.8% Mar 31, 2012
Q4 2011 132 Dec 31, 2011
Q3 2011 115 Sep 30, 2011
Q2 2011 122 Jun 30, 2011
Q1 2011 121 Mar 31, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.